ロード中...
Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
BACKGROUND: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....
保存先:
| 出版年: | J Infect Public Health |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871101/ https://ncbi.nlm.nih.gov/pubmed/33866129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.01.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|